A-SPINE Asia Co., Ltd. (TPEX:6758)
Taiwan · Delayed Price · Currency is TWD 29.25
0.00 (0.00%)
Jul 20, 2026, 9:54 AM CST
A-SPINE Asia Market Cap
A-SPINE Asia has a market cap or net worth of 394.03 million as of July 21, 2026. Its market cap has decreased by -22.72% in one year.
Market Cap
394.03M
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
29.25
ChartMarket Cap Chart
Since January 2, 2020, A-SPINE Asia's market cap has decreased from 1.20B to 394.03M, a decrease of -67.13%. That is a compound annual growth rate of -15.62%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 20, 2026 | 394.03M | -25.95% |
| Dec 31, 2025 | 532.11M | -1.00% |
| Dec 30, 2024 | 537.49M | 2.57% |
| Dec 29, 2023 | 524.02M | 2.37% |
| Dec 30, 2022 | 511.90M | -19.23% |
| Dec 10, 2021 | 633.81M | -18.88% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jan 2, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cowealth Medical Holding | 1.06B |
| Wiltrom | 997.22M |
| S&S Healthcare Holding | 967.94M |
| PlexBio | 879.98M |
| Radiant Innovation | 785.71M |
| Carilex Medical | 648.71M |
| AmCad BioMed | 623.83M |
| Health & Life | 561.78M |